Second, there is a popular study about the new biomarkers to monitor NAFLD, such as Sirtuin 1, CK-18, and more genetic and epigenetic factors (42, 44, 45). This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.